cosentyx
novartis europharm limited - secukinumab - arthritis, psoriatic; psoriasis; spondylitis, ankylosing - immunsuppressiva - plaque psoriasiscosentyx is indicated for the treatment of moderate to severe plaque psoriasis in adults and children from the age of 6 years old who are candidates for systemic therapy. hidradenitis suppurativa (hs)cosentyx is indicated for the treatment of active moderate to severe hidradenitis suppurativa (acne inversa) in adults with an inadequate response to conventional systemic hs therapy. psoriasisartrit arthritiscosentyx, ensamt eller i kombination med metotrexat (mtx), är indicerat för behandling av aktiv psoriasisartrit hos vuxna patienter, när svaret på tidigare sjukdomsmodifierande anti-reumatiska läkemedel (dmard) terapi har varit otillräcklig. axiell spondyloarthritis (axspa)ankyloserande spondylit (as, röntgen axiell spondyloarthritis)cosentyx är indicerat för behandling av aktiv ankyloserande spondylit hos vuxna som svarat otillräckligt för att konventionell terapi. non-radiographic axial spondyloarthritis (nr-axspa)cosentyx is indicated for the treatment of active non-radiographic axial spondyloarthritis with objective signs of inflammation as indicated by elevated c-reactive protein (crp) and/or magnetic resonance imaging (mri) evidence in adults who have responded inadequately to non steroidal anti inflammatory drugs (nsaids). juvenile idiopathic arthritis (jia)enthesitis-related arthritis (era)cosentyx, alone or in combination with methotrexate (mtx), is indicated for the treatment of active enthesitis-related arthritis in patients 6 years and older whose disease has responded inadequately to, or who cannot tolerate, conventional therapy. juvenile psoriatic arthritis (jpsa)cosentyx, alone or in combination with methotrexate (mtx), is indicated for the treatment of active juvenile psoriatic arthritis in patients 6 years and older whose disease has responded inadequately to, or who cannot tolerate, conventional therapy.
sylvant
recordati netherlands b.v. - siltuximab - giant lymfkörtelplastik - immunsuppressiva - sylvant är indicerat för behandling av vuxna patienter med multicentrisk castlemans sjukdom (mcd som är humant immunbristvirus (hiv) negativ och human herpesvirus-8 (hhv-8) negativ.
kyntheum
leo pharma a/s - brodalumab - psoriasis - immunsuppressiva - kyntheum är indicerat för behandling av måttlig till svår plackpsoriasis hos vuxna patienter som är kandidater till systemisk terapi.
skyrizi
abbvie deutschland gmbh & co. kg - risankizumab - psoriasis; arthritis, psoriatic - immunsuppressiva - plaque psoriasisskyrizi is indicated for the treatment of moderate to severe plaque psoriasis in adults who are candidates for systemic therapy. psoriatic arthritisskyrizi, alone or in combination with methotrexate (mtx), is indicated for the treatment of active psoriatic arthritis in adults who have had an inadequate response or who have been intolerant to one or more disease-modifying antirheumatic drugs (dmards). crohn's diseaseskyrizi is indicated for the treatment of adult patients with moderately to severely active crohn's disease who have had an inadequate response to, lost response to, or were intolerant to conventional therapy or a biologic therapy.
lupkynis
otsuka pharmaceutical netherlands b.v. - voclosporin - lupus nephritis - immunsuppressiva - lupkynis is indicated in combination with mycophenolate mofetil for the treatment of adult patients with active class iii, iv or v (including mixed class iii/v and iv/v) lupus nephritis (ln).
spevigo
boehringer ingelheim international gmbh - spesolimab - psoriasis - immunsuppressiva - spevigo is indicated for the treatment of flares in adult patients with generalised pustular psoriasis (gpp) as monotherapy.
sandimmun neoral 10 mg kapsel, mjuk
novartis sverige ab - ciklosporin - kapsel, mjuk - 10 mg - ciklosporin 10 mg aktiv substans; propylenglykol hjälpämne; glycerol 85% hjälpämne; makrogolglycerolhydroxistearat hjälpämne; etanol, vattenfri hjälpämne - ciklosporin
ciqorin 10 mg kapsel, mjuk
teva sweden ab - ciklosporin - kapsel, mjuk - 10 mg - etanol, vattenfri hjälpämne; ciklosporin 10 mg aktiv substans; makrogolglycerolhydroxistearat hjälpämne; glycerol 85% hjälpämne; sorbitol hjälpämne - ciklosporin
sandimmun neoral 100 mg kapsel, mjuk
novartis sverige ab - ciklosporin - kapsel, mjuk - 100 mg - ciklosporin 100 mg aktiv substans; propylenglykol hjälpämne; etanol, vattenfri hjälpämne; glycerol 85% hjälpämne; makrogolglycerolhydroxistearat hjälpämne - ciklosporin
sandimmun neoral 100 mg kapsel, mjuk
medartuum ab - ciklosporin - kapsel, mjuk - 100 mg - ciklosporin 100 mg aktiv substans; propylenglykol hjälpämne; glycerol 85% hjälpämne; makrogolglycerolhydroxistearat hjälpämne; etanol, vattenfri hjälpämne - ciklosporin